Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

2.

Long-term quality of life after ablation of atrial fibrillation the impact of recurrence, symptom relief, and placebo effect.

Wokhlu A, Monahan KH, Hodge DO, Asirvatham SJ, Friedman PA, Munger TM, Bradley DJ, Bluhm CM, Haroldson JM, Packer DL.

J Am Coll Cardiol. 2010 May 25;55(21):2308-16. doi: 10.1016/j.jacc.2010.01.040.

3.

Health-related quality of life in patients with atrial fibrillation treated with rhythm control versus rate control: insights from a prospective international registry (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation: RECORD-AF).

Ha AC, Breithardt G, Camm AJ, Crijns HJ, Fitzmaurice GM, Kowey PR, Le Heuzey JY, Naditch-Brûlé L, Prystowsky EN, Schwartz PJ, Torp-Pedersen C, Weintraub WS, Dorian P.

Circ Cardiovasc Qual Outcomes. 2014 Nov;7(6):896-904. doi: 10.1161/HCQ.0000000000000011. Epub 2014 Nov 11.

4.

Healthcare resource utilization and costs associated with recurrent episodes of atrial fibrillation: the FRACTAL registry.

Reynolds MR, Essebag V, Zimetbaum P, Cohen DJ.

J Cardiovasc Electrophysiol. 2007 Jun;18(6):628-33. Epub 2007 Apr 19.

5.

The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy.

Dorian P, Jung W, Newman D, Paquette M, Wood K, Ayers GM, Camm J, Akhtar M, Luderitz B.

J Am Coll Cardiol. 2000 Oct;36(4):1303-9.

6.

Effect of rate or rhythm control on quality of life in persistent atrial fibrillation. Results from the Rate Control Versus Electrical Cardioversion (RACE) Study.

Hagens VE, Ranchor AV, Van Sonderen E, Bosker HA, Kamp O, Tijssen JG, Kingma JH, Crijns HJ, Van Gelder IC; RACE Study Group.

J Am Coll Cardiol. 2004 Jan 21;43(2):241-7.

7.

Symptoms, functional status and quality of life in patients with controlled and uncontrolled atrial fibrillation: data from the RealiseAF cross-sectional international registry.

Steg PG, Alam S, Chiang CE, Gamra H, Goethals M, Inoue H, Krapf L, Lewalter T, Merioua I, Murin J, Naditch-Brûlé L, Ponikowski P, Rosenqvist M, Silva-Cardoso J, Zharinov O, Brette S, Neill JO; RealiseAF investigators.

Heart. 2012 Feb;98(3):195-201. doi: 10.1136/heartjnl-2011-300550. Epub 2011 Sep 22.

PMID:
21948959
8.

Improvements in symptoms and quality of life in patients with paroxysmal atrial fibrillation treated with radiofrequency catheter ablation versus antiarrhythmic drugs.

Reynolds MR, Walczak J, White SA, Cohen DJ, Wilber DJ.

Circ Cardiovasc Qual Outcomes. 2010 Nov;3(6):615-23. doi: 10.1161/CIRCOUTCOMES.110.957563. Epub 2010 Oct 12.

9.

Validation of a new simple scale to measure symptoms in atrial fibrillation: the Canadian Cardiovascular Society Severity in Atrial Fibrillation scale.

Dorian P, Guerra PG, Kerr CR, O'Donnell SS, Crystal E, Gillis AM, Mitchell LB, Roy D, Skanes AC, Rose MS, Wyse DG.

Circ Arrhythm Electrophysiol. 2009 Jun;2(3):218-24. doi: 10.1161/CIRCEP.108.812347. Epub 2009 Mar 31.

10.

A cross-sectional study of quality of life in an elderly population (75 years and over) with atrial fibrillation: secondary analysis of data from the Birmingham Atrial Fibrillation Treatment of the Aged study.

Roalfe AK, Bryant TL, Davies MH, Hackett TG, Saba S, Fletcher K, Lip GY, Hobbs FD, Mant J; BAFTA investigators.

Europace. 2012 Oct;14(10):1420-7. Epub 2012 May 10.

11.

Quality of life improves with treatment in the Canadian Trial of Atrial Fibrillation.

Dorian P, Paquette M, Newman D, Green M, Connolly SJ, Talajic M, Roy D.

Am Heart J. 2002 Jun;143(6):984-90.

PMID:
12075253
12.

Quality of life in atrial fibrillation: the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study.

Jenkins LS, Brodsky M, Schron E, Chung M, Rocco T Jr, Lader E, Constantine M, Sheppard R, Holmes D, Mateski D, Floden L, Prasun M, Greene HL, Shemanski L.

Am Heart J. 2005 Jan;149(1):112-20.

PMID:
15660042
13.

The effect of rate control on quality of life in patients with permanent atrial fibrillation: data from the RACE II (Rate Control Efficacy in Permanent Atrial Fibrillation II) study.

Groenveld HF, Crijns HJ, Van den Berg MP, Van Sonderen E, Alings AM, Tijssen JG, Hillege HL, Tuininga YS, Van Veldhuisen DJ, Ranchor AV, Van Gelder IC; RACE II Investigators.

J Am Coll Cardiol. 2011 Oct 18;58(17):1795-803. doi: 10.1016/j.jacc.2011.06.055.

14.

Effect of continuous versus episodic amiodarone treatment on quality of life in persistent atrial fibrillation.

Ahmed S, Ranchor AV, Crijns HJ, Van Veldhuisen DJ, Van Gelder IC; CONVERT investigators.

Europace. 2010 Jun;12(6):785-91. doi: 10.1093/europace/euq049. Epub 2010 Mar 2.

15.

Real-life observations of clinical outcomes with rhythm- and rate-control therapies for atrial fibrillation RECORDAF (Registry on Cardiac Rhythm Disorders Assessing the Control of Atrial Fibrillation).

Camm AJ, Breithardt G, Crijns H, Dorian P, Kowey P, Le Heuzey JY, Merioua I, Pedrazzini L, Prystowsky EN, Schwartz PJ, Torp-Pedersen C, Weintraub W.

J Am Coll Cardiol. 2011 Jul 26;58(5):493-501. doi: 10.1016/j.jacc.2011.03.034.

16.

Effect of left atrial ablation on the quality of life in patients with atrial fibrillation.

Miyazaki S, Kuwahara T, Takahashi A, Kobori A, Takahashi Y, Nozato T, Hikita H, Sato A, Aonuma K, Hirao K, Isobe M.

Circ J. 2008 Apr;72(4):582-7.

17.

Quality of life and functional capacity in patients with atrial fibrillation and congestive heart failure.

Suman-Horduna I, Roy D, Frasure-Smith N, Talajic M, Lespérance F, Blondeau L, Dorian P, Khairy P; AF-CHF Trial Investigators.

J Am Coll Cardiol. 2013 Jan 29;61(4):455-60. doi: 10.1016/j.jacc.2012.10.031. Epub 2012 Dec 19.

19.

Successful pulmonary vein isolation using transvenous catheter cryoablation improves quality-of-life in patients with atrial fibrillation.

Tse HF, Sin PY, Siu CW, Tsang V, Lam CL, Lau CP.

Pacing Clin Electrophysiol. 2005 May;28(5):421-4.

PMID:
15869674
20.

Role of gender and personality on quality-of-life impairment in intermittent atrial fibrillation.

Paquette M, Roy D, Talajic M, Newman D, Couturier A, Yang C, Dorian P.

Am J Cardiol. 2000 Oct 1;86(7):764-8.

PMID:
11018197
Items per page

Supplemental Content

Write to the Help Desk